The development of gene therapy for the treatment of cancer.

od Rosenberg, S A, Anderson, W F, Blaese, M, Hwu, P, Yannelli, J R, Yang, J C, Topalian, S L, Schwartzentruber, D J, Weber, J S, Ettinghausen, S E
Izdano 1993

Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.

od Cohen, O J, Vaccarezza, M, Lam, G K, Baird, B F, Wildt, K, Murphy, P M, Zimmerman, P A, Nutman, T B, Fox, C H, Hoover, S, Adelsberger, J, Baseler, M, Arthos, J, Davey, R T, Dewar, R L, Metcalf, J, Schwartzentruber, D J, Orenstein, J M, Buchbinder, S, Saah, A J, Detels, R, Phair, J, Rinaldo, C, Margolick, J B, Fauci, A S
Izdano 1997